On Wednesday, Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.7 which represents a decrease of $-0.11 or -1.25% from the prior close of $8.81. The stock opened at $8.9 and ...

Amneal Pharmaceuticals Inc (AMRX) reports a 17% revenue increase and raises 2024 guidance amid key product launches and strategic developments. BRIDGEWATER, N.J. & NEW YORK, October 01 ...

Amneal is releasing Crexont (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease.

The company which started operations in India in 2008, currently has 8 manufacturing sites, including 5 in Ahmedabad with ...

Here is how Amneal Pharmaceuticals (AMRX) and Astrazeneca (AZN) have performed compared to their sector so far this year.

Metsera, a biotech focused on obesity drugs that came out of stealth this year, said Tuesday that it is partnering with drug manufacturer Amneal Pharmaceuticals to produce injectable and oral ...

Nasdaq-listed Amneal Pharmaceuticals, which already operates multiple manufacturing facilities in Gujarat, is further ...

JP Morgan has recently raised Amneal Pharmaceuticals Inc (AMRX) stock to Neutral rating, as announced on September 6, 2024, according to Finviz. Earlier, on April 7, 2021, RBC Capital Mkts had resumed ...

Amneal Pharmaceuticals will invest up to $200 million in India over the next four to five years to build two new ...

(RTTNews) - Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and large-scale supply of a portfolio of new weight loss ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, and Metsera, Inc. ("Metsera"), a clinical-stage biopharmaceutical company accelerating the ...

Has Amneal Pharmaceuticals (AMRX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...